Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Pharmaceutical application of hydrogen sulfide synthase CSE

A technology for synthesizing enzymes and hydrogen sulfide, applied in the field of biomedicine, to achieve the effect of improving endothelial injury, reducing aortic aneurysm and aortic dissection

Inactive Publication Date: 2021-05-25
NANJING MEDICAL UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, whether hydrogen sulfide changes during the occurrence of aortic aneurysm and aortic dissection, and whether its dysfunction is involved in the development of aortic aneurysm and aortic dissection, there are still no relevant studies

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical application of hydrogen sulfide synthase CSE
  • Pharmaceutical application of hydrogen sulfide synthase CSE
  • Pharmaceutical application of hydrogen sulfide synthase CSE

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] 1. Western-Blot

[0019] (1) SDS-PAGE (polyacrylamide gel) electrophoresis: Prepare 12% separating gel and 3% stacking gel. Take 15 μL sample solution and 3 μL 6× loading buffer, and mix well. After boiling for 5 min to denature the protein, the sample was loaded with an amount of about 30 μg per well. Electrophoresis at a constant voltage of 110 V for about 90 min until bromophenol blue completely disappeared.

[0020] Preparation of SDS-PAGE:

[0021] Components Separating Gel (12%) Stacking Gel (3%)

[0022] Deionized water 1.6 mL 1.8 mL

[0023] 30% AA stock solution 2.0 mL 0.3 mL

[0024] 1.5M Tris-HCl (pH8.8) 1.3 mL ---

[0025] 1 M Tris-HCl (pH6.8) --- 0.75 mL

[0026] 10% SDS 50 μL 30 μL

[0027] 10% ammonium persulfate (APS) 50 μL 50 μL

[0028] TEMED 5 μL 5 μL

[0029] Total volume 5 mL 3 mL

[0030] (2) Membrane transfer: After electrophoresis, cut off the stacking gel, soak the gel in protein transfer buffer (3.6 g / L Tris, 300 mL / L methanol, 17.3 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to pharmaceutical application of hydrogen sulfide synthase (CSE), in particular to application in preparation of drugs for treating aortic aneurysm and aortic dissection. The CSE adeno-associated virus improves the endothelial function and inhibits the onset of aortic aneurysm and aortic dissection. According to the invention, the effect of the hydrogen sulfide synthase CSE on endothelial injury caused by mechanical traction and prevention of aortic aneurysm and aortic dissection is defined. A new means is provided for treating the main aneurysm and the aortic dissection.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and in particular relates to the pharmaceutical use of hydrogen sulfide synthase CSE. Background technique [0002] Aortic aneurysm (AoA) and aortic dissection (AoD) are multifactorially induced and potentially fatal vascular diseases with a genetic predisposition. Aortic aneurysm manifests as aneurysmal dilation of the aorta, which is defined as dilation of the artery greater than 1.5 times the normal arterial diameter. Aortic dissection is manifested by tearing of the intima of the aortic wall, and circulating blood enters the media of the aortic wall through the intima breach, resulting in a large-scale tear of the media and the formation of a dissection. The etiology of more than 80% of patients with AoA and AoD is hypertension. According to statistics, AoA and AoD account for 1%-3% of the mortality rate of adult males aged 65-85 in developed countries. The pathological mechanisms of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/51A61K48/00A61P35/00A61P9/00
CPCA61K38/51A61K48/005A61P9/00A61P35/00C12Y404/01001
Inventor 季勇罗姗姗孔垂玉周雪纯
Owner NANJING MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com